Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments.

52W Range

8thpctl

Volume

0.08×avg

Market Cap

5.51MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Pulmatrix, Inc.

PULMNASDAQ Capital Market·USD·Closed

Pulmatrix, Inc.

PULMNASDAQ·USD·Closed

$1.51

−0.66%

$1.51

−$0.01 (0.66%)

52W Range

8thpctl

Volume

0.08×avg

Mkt Cap

5.51MUSD

P/E

-1.4TTM

Div Yield

–ann

PULM: Pulmatrix, Inc. Stock Analysis | finqOS